Publications
Stay updated with Dei BioPharma’s latest breakthroughs, milestones, and industry insights in pharmaceutical innovation.
Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery—A Humanitarian Cause
Recombinant therapeutic and vaccine proteins have revolutionized healthcare, but there remain challenges, as many are awaiting development due to their...
Current Progress and Future Perspectives of RNA-Based Cancer Vaccines: A 2025 Update
RNA-based cancer vaccines are a breakthrough treatment that trains the immune system to recognize and attack specific cancer cells. Recent...
RNA Cancer Vaccines Show Breakthrough Potential, With First Approvals Expected by 2029
RNA-based cancer vaccines have emerged as a revolutionary immunotherapy, fueled by advances in mRNA technology and personalized medicine. Recent clinical...
GLP-1 Receptor Agonists: Chemical Evolution and Expanding Clinical Applications
Matthias Magoola DEI Biopharma, Kampala, Uganda; dei@deigroupinternational.com Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed modern medicine, progressing from diabetes treatments to...
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis
PUBLICATION BY DR. MATTHIAS MAGOOLA, CHEMIST Abstract: MicroRNAs (miRNAs) maintain cellular homeostasis by blocking mRNAs by binding with them to fine-tune...
Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Alzheimer’s disease (AD) remains a significant challenge in the field of neurodegenerative disorders, even nearly...
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Antibodies that can selectively remove rogue proteins in the brain are an obvious choice to...
Unlocking the Future of Drug Development: Generative AI, Digital Twins, and Beyond
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: This article delves into the intersection of generative AI and digital twins within drug discovery,...
Synergistic Approaches in Neurodegenerative Therapeutics: 2 Multi-Target Drug Innovative Interventions for Alzheimer’s 3 Disease
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Alzheimer’s disease (AD) remains a significant challenge in the field of neurodegenerative 10 disorders, even...